Structure Therapeutics
GPCR
GPCR
197 hedge funds and large institutions have $4.58B invested in Structure Therapeutics in 2025 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 52 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
26% more funds holding
Funds holding: 156 → 197 (+41)
10.07% more ownership
Funds ownership: 98.33% → 108.4% (+10%)
16% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 62
Holders
197
Holding in Top 10
16
Calls
$62.6M
Puts
$18.2M
Top Buyers
| 1 | +$141M | |
| 2 | +$61.7M | |
| 3 | +$58.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$57.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$56.4M |
Top Sellers
| 1 | -$45.8M | |
| 2 | -$42.5M | |
| 3 | -$38.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$18M |
| 5 |
CCM
Catalio Capital Management
New York
|
-$16.3M |
